Pancreatic neuroendocrine tumors: A case-based evidence review

doi:10.4291/wjgp.v16.i2.107265

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (26)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

HTML

Figures (1-4)

Tables (1-3)

Sum=25

Jun 22, 2025 (publication date) through Jun 19, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pathophysiology

ISSN

2150-5330

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Evidence Review

World J Gastrointest Pathophysiol. Jun 22, 2025; 16(2): 107265
Published online Jun 22, 2025. doi: 10.4291/wjgp.v16.i2.107265

Full Size Figure Download Figure

Figure 1 Management of pancreatic neuroendocrine tumors, according to functional status, adapted from European neuroendocrine tumor society 2023[33,34]. SSR: Somatostatin receptor, SSA: Somatostatin analog; PRRT: Peptide receptor radionuclide therapy.

Citation: Rikhraj N, Fernandez CJ, Ganakumar V, Pappachan JM. Pancreatic neuroendocrine tumors: A case-based evidence review. World J Gastrointest Pathophysiol 2025; 16(2): 107265
URL: https://www.wjgnet.com/2150-5330/full/v16/i2/107265.htm
DOI: https://dx.doi.org/10.4291/wjgp.v16.i2.107265